Spectranetics (SPNC) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Meta CEO Mark Zuckerberg Says In Internal Town Hall That Ai Agent Development Over The Last Four Months Hasn't 'accelerated In The Way We Expected' - Reuters
Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
April 23, 2015 4:03 PM EDTExpands Stellarex Program to Below the Knee Market
Updates 2015 Outlook
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq: SPNC) today reported financial results for the three months ended March 31, 2015. Highlights of the quarter, all compared with the three months ended March 31, 2014 include:
Revenue of $57.4 million, up 45% (47% constant currency1) Vascular Intervention revenue of $36.5 million grew 82% (84% constant currency) U.S. peripheral atherectomy revenue grew 16% AngioSculpt® revenue of $14.0 million achieved Lead Management revenue of $16.4 million increased 14% (16% constant... More